Membrane and Peripheral Enzyme Expression Services

inquiry

Creative Enzymes provides specialized Membrane and Peripheral Enzyme Expression Services designed to overcome the technical challenges associated with producing membrane-bound and membrane-associated biocatalysts. These enzymes are often difficult to express due to hydrophobic domains, structural instability, low solubility, and toxicity to host cells. Our integrated platform combines optimized host selection, codon optimization, fusion-tag engineering, detergent and lipid system screening, and advanced purification strategies to deliver functional, high-quality enzymes. We support research, pharmaceutical, and industrial clients by ensuring reliable expression, stabilization, and characterization of complex membrane enzymes while preserving catalytic activity and structural integrity.

Crystal structure of phospholipase A2

Background: Technical Challenges in Membrane and Peripheral Enzyme Expression

Membrane and peripheral enzymes play essential roles in cellular metabolism, signal transduction, drug metabolism, redox regulation, and transport processes. These enzymes are frequently embedded within lipid bilayers or loosely associated with membranes through electrostatic or hydrophobic interactions. Despite their biological importance, they remain among the most challenging protein classes to express and purify.

The difficulty stems from several inherent properties:

Hydrophobic transmembrane domains that promote aggregation when expressed in heterologous systems.
Dependence on lipid environments for proper folding and activity.
Low expression levels due to toxicity or metabolic burden on host cells.
Proteolytic degradation caused by structural instability outside native membranes.
Requirement for cofactors or partner proteins for proper enzymatic activity.

Membrane-bound oxidoreductases, cytochrome P450 systems, transport-associated hydrolases, and membrane-associated transferases are particularly challenging targets. Traditional soluble protein expression platforms are often insufficient, resulting in inclusion bodies, low yields, or inactive protein.

Creative Enzymes has developed a dedicated expression and stabilization platform specifically for membrane and peripheral enzymes. By combining molecular biology, protein engineering, membrane-mimetic systems, and purification optimization, we enable the production of active, structurally intact enzymes suitable for downstream applications.

What We Offer: Comprehensive Membrane and Peripheral Enzyme Expression Solutions

Creative Enzymes provides a full-service solution covering every stage from gene design to functional validation. Our services include:

Gene Optimization and Construct Engineering

Codon optimization tailored to host systems.
Truncation of unstable signal peptides or non-essential hydrophobic regions.
Design of expression constructs for full-length or soluble domains.

Multi-Platform Expression Systems

Bacterial systems (e.g., E. coli strains optimized for membrane proteins).
Yeast systems for improved folding and post-translational modifications.
Insect cell systems using baculovirus expression.
Mammalian cell expression for complex membrane enzymes.
Cell-free expression systems for highly toxic targets.

Fusion Tag and Solubility Enhancement

N- or C-terminal fusion partners.
Affinity purification tags.
Cleavable solubility-enhancing domains.

Membrane-Mimetic Stabilization Strategies

Detergent screening.
Liposome reconstitution.
Nanodisc technology.
Amphipol stabilization.

Co-Expression of Accessory Proteins

Chaperones.
Redox partners.
Cofactor-synthesizing enzymes.

Purification and Analytical Characterization

Affinity chromatography.
Size-exclusion chromatography.
Activity assays under membrane-mimicking conditions.
Structural and stability assessment.

Our objective is to deliver functional, reproducible enzyme preparations with scalable production options.

Inquiry

Service Workflow

Workflow of membrane and peripheral enzyme expression services

Advanced Technical Capabilities for Membrane and Peripheral Enzymes

Specialized Host Systems: Certain engineered bacterial strains are optimized for membrane protein overexpression with reduced toxicity. Yeast and insect systems provide enhanced folding and limited glycosylation capabilities. Mammalian systems are selected when complex modifications are essential.
Detergent and Lipid Screening Platforms: Membrane enzymes require carefully selected detergents to maintain structural integrity. We maintain a comprehensive detergent panel and lipid library to identify optimal solubilization conditions while preserving activity.
Nanodisc and Liposome Reconstitution: Nanodisc technology enables incorporation of membrane proteins into a defined lipid bilayer environment, enhancing stability and enabling functional assays under near-native conditions.
Cofactor and Redox Partner Integration: For enzymes such as oxidoreductases, co-expression or in vitro reconstitution with accessory proteins ensures full catalytic functionality.
Stability Engineering: When instability limits production, we apply the appropriate engineering strategies, including rational mutagenesis, loop rigidification, surface charge optimization, and fusion stabilization.
Analytical Platforms: We provide analytical methods including SDS-PAGE and western blot validation, spectroscopic analysis, kinetic parameter determination (K_m, V_max), thermal shift assays, and aggregation profiling.

Contact Our Team

Why Choose Creative Enzymes for Membrane and Peripheral Enzyme Expression

Dedicated Membrane Protein Expertise

Our team has extensive experience handling hydrophobic, multi-pass, and membrane-associated enzymes.

Integrated Expression Platforms

Access to bacterial, yeast, insect, mammalian, and cell-free systems ensures flexibility.

Advanced Membrane-Mimetic Technologies

We offer nanodisc reconstitution, liposome systems, and amphipol stabilization.

Customized Strategy Development

Each project receives a tailored approach based on enzyme topology and application.

Comprehensive Quality Control

Functional validation ensures that enzymes are not only expressed but fully active.

Scalable Production Capability

Processes are designed to transition from research scale to pilot or industrial scale.

Case Studies: Membrane and Peripheral Enzyme Expression Successes

Case 1: Tunable Lemo21(DE3) Platform for Membrane Protein Overexpression

To overcome toxicity and low yields in membrane protein production, researchers investigated the improved performance of the Walker strains C41(DE3) and C43(DE3). Mutations in the lacUV5 promoter regulating T7 RNA polymerase were identified as key factors enabling reduced toxicity and enhanced membrane protein overexpression. Building on this insight, a tunable strain, Lemo21(DE3), was engineered to precisely control T7 RNA polymerase activity via its natural inhibitor, T7 lysozyme. This system allows fine adjustment of expression levels using a single host strain, improving yields and simplifying optimization. The approach provides a flexible and high-throughput solution for membrane and peripheral protein expression.

Tuning Escherichia coli for membrane protein overexpression Figure 1. Growth and Expression Analysis of YidC-GFP in E. coli Strains. (A–B) Cell growth (A600) and YidC-GFP expression (GFP fluorescence) monitored every 30 min. (C–F) Flow cytometry analysis of cell size, granularity, and GFP expression 4 h after IPTG induction. (G) Hourly oxygen consumption measurements. (Wagner et al., 2008)

Case 2: Recombinant Expression and Purification of Membrane-Bound DGAT2

Diacylglycerol acyltransferase 2 (DGAT2), a membrane-bound enzyme catalyzing the rate-limiting step of triacylglycerol biosynthesis, was expressed recombinantly in Escherichia coli as a maltose-binding protein and His-tag fusion. The protein localized to soluble, insoluble, and membrane fractions and required detergent solubilization, with SDS proving most effective for purification. Affinity chromatography and mass spectrometry confirmed monomeric and dimeric forms associated with lipids and other proteins. Although purified protein was obtained from E. coli, enzymatic activity was detected only in Saccharomyces cerevisiae, indicating that proper folding or post-translational modifications are essential for functional expression of this complex membrane enzyme.

Expression and purification of recombinant tung tree diacylglycerol acyltransferase 2 Figure 2. Expression and Identification of rDGAT2 in E. coli. (a) rDGAT2 expression in E. coli BL21(DE3) following IPTG induction, detected by anti-MBP antibodies. MBP-mTTP served as a positive control. (b) Affinity purification of rDGAT2 using amylose resin; eluted fractions (E1–E3) were analyzed by SDS-PAGE. (Cao et al., 2012)

Frequently Asked Questions (FAQs)

Q: What defines a membrane or peripheral enzyme?

A: Membrane enzymes are embedded within lipid bilayers, often containing transmembrane helices. Peripheral enzymes associate with membranes through non-covalent interactions without spanning the membrane.
Q: Why are membrane enzymes difficult to express?

A: Their hydrophobic domains promote aggregation and require lipid environments for proper folding. Overexpression may also cause host toxicity.
Q: Can you express full-length multi-pass membrane proteins?

A: Yes. We design constructs specifically for multi-pass proteins and optimize detergent and lipid conditions to preserve functionality.
Q: How do you maintain enzyme activity after purification?

A: We use membrane-mimetic systems such as nanodiscs or liposomes and select detergents that stabilize protein structure.
Q: Do you offer co-expression of partner proteins?

A: Yes. For enzymes requiring redox partners or cofactors, we provide co-expression or reconstitution strategies.
Q: What scale of production is available?

A: We support small-scale research quantities and can scale up to pilot production levels depending on project needs.
Q: How long does a typical project take?

A: Timelines vary based on complexity. Initial expression screening may take several weeks, while full optimization and scale-up may require several months.

References:

Cao H, Chapital DC, Howard OD, et al. Expression and purification of recombinant tung tree diacylglycerol acyltransferase 2. Appl Microbiol Biotechnol. 2012;96(3):711-727. doi:10.1007/s00253-012-3869-7
Wagner S, Klepsch MM, Schlegel S, et al. Tuning Escherichia coli for membrane protein overexpression. Proc Natl Acad Sci USA. 2008;105(38):14371-14376. doi:10.1073/pnas.0804090105

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry